![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/09 | |
A61P 31/18 | |||
A61P 37/04 | |||
A61P 5/08 | |||
A61K 45/06 |
(11) | Number of the document | 2307040 |
(13) | Kind of document | T |
(96) | European patent application number | 09755128.7 |
Date of filing the European patent application | 2009-05-18 | |
(97) | Date of publication of the European application | 2011-04-13 |
(45) | Date of publication and mention of the grant of the patent | 2015-09-09 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/SE2009/000255 |
Date | 2009-05-18 |
(87) | Number | WO 2009/145690 |
Date | 2009-12-03 |
(30) | Number | Date | Country code |
0801255 | 2008-05-29 | SE |
(72) |
LJUNGBLAD, Ulf, SE
BACKSTRĂ–M LUNDGREN, Yen, SE
WINQVIST, Ola, SE
|
(73) |
Isr Immune System Regulation Ab,
Avd L2:04 Karolinska universitetssjukhuset Solna, 17176 Stockholm,
SE
|
(54) | USE OF GNRH AND SEX HORMONES FOR TREATING VIRAL DISEASE, IN PARTICULAR HIV/AIDS |
USE OF GNRH AND SEX HORMONES FOR TREATING VIRAL DISEASE, IN PARTICULAR HIV/AIDS |